Home
Eystein Sverre Husebye's picture

Eystein Sverre Husebye

Professor
  • E-mailEystein.Husebye@uib.no
  • Phone+47 55 97 30 78
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen

Addison's disease

Autoimmune polyendocrine disorders

Hypoparathyroidism

Endocrinology

Academic article
  • 2019. HbA1c predicts long-term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study. Journal of Diabetes.
  • 2018. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. Journal of Clinical Endocrinology and Metabolism. 1696-1703.
  • 2018. Oral tongue malignancies in Autoimmune polyendocrine syndrome type 1. Frontiers in Endocrinology. 1-9.
  • 2018. Metabolic complications in adrenal insufficiency. Frontiers of Hormone Research. 104-113.
  • 2018. Is there a need for an emergency card in hypoparathyroidism? Journal of Internal Medicine. 1-7.
  • 2018. High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial. Nutrition - The International Journal of Applied and Basic Nutritional Sciences. 66-73.
  • 2018. HbA1c predicts long-term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study. Journal of Diabetes. 1-11.
  • 2018. Autoimmune Addison's disease – An update on pathogenesis. Annales d'Endocrinologie. 157-163.
  • 2018. Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency. Endocrine Connections. 1542-1550.
  • 2018. Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion. Journal of Clinical Endocrinology and Metabolism. 4553-4560.
  • 2018. A wide spectrum of autoimmune manifestations and other symptoms suggesting immune dysregulation in patients with cartilage-hair hypoplasia. Frontiers in Immunology.
  • 2017. Clues for early detection of autoimmune Addison's disease - myths and realities. Journal of Internal Medicine. 190-199.
  • 2017. Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins. Frontiers in Immunology.
  • 2017. Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins. Frontiers in Immunology.
  • 2016. Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. Scientific Reports.
  • 2016. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. Journal of Clinical Endocrinology and Metabolism. 3045-3053.
  • 2016. Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. European Journal of Endocrinology. 97-105.
  • 2016. Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Journal of Immunology. 2955-2964.
  • 2016. Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. Journal of Translational Medicine.
  • 2016. Adrenal insufficiency therapy: How to keep the balance between good quality of life and low risk for long-term side effects? Frontiers of Hormone Research. 196-210.
  • 2016. Abdominal aortic aneurysms - glycaemic status and mortality. Journal of diabetes and its complications. 438-443.
  • 2016. A variant in the BACH2 gene is associated with susceptibility to autoimmune addison's disease in humans. Journal of Clinical Endocrinology and Metabolism. 3865-3869.
  • 2016. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 2975-2983.
  • 2015. Transglutaminase 4 as a prostate autoantigen in male subfertility. Science Translational Medicine.
  • 2015. The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. Nature Immunology. 737-745.
  • 2015. Peripheral blood cells from patients with autoimmune Addison's disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines. Journal of Interferon and Cytokine Research. 759-770.
  • 2015. Linkage analysis in autoimmune Addison's disease: NFATC1 as a potential novel susceptibility locus. PLOS ONE.
  • 2015. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis. Autoimmunity. 100-107.
  • 2015. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. Endocrine Connections. 215-222.
  • 2015. En mann i 30-årene med diabetes og vitiligo. Tidsskrift for Den norske legeforening. 763-766.
  • 2015. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 1185-1196.
  • 2015. Determination of 21-hydroxylase autoantibodies: Inter-laboratory concordance in the Euradrenal International Serum Exchange Program. Clinical Chemistry and Laboratory Medicine. 1761-1770.
  • 2015. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. Clinical Endocrinology. 28-35.
  • 2015. CTLA-4 as a genetic determinant in autoimmune Addison's disease. Genes and Immunity. 430-436.
  • 2014. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. Clinical and Experimental Immunology. 351-362.
  • 2014. High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. Journal of Immunology. 2118-2126.
  • 2014. Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocrine Connections. 67-74.
  • 2014. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. Journal of Clinical Endocrinology and Metabolism. 1665-1674.
  • 2014. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Journal of Internal Medicine. 104-115.
  • 2014. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. Journal of Immunology. 3880-3890.
  • 2014. CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. European Journal of Endocrinology. 743-750.
  • 2014. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. PLOS ONE.
  • 2014. Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. Molecular Immunology. 208-216.
  • 2014. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. Clinical Immunology. 220-227.
  • 2013. Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease. Clinical Endocrinology. 316-320.
  • 2013. MHC class II association study in eight breeds of dog with hypoadrenocorticism. Immunogenetics. 291-297.
  • 2013. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3. Molecular and Cellular Endocrinology. 75-83.
  • 2013. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Science Translational Medicine. 10 pages.
  • 2013. Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. Immunobiology. 899-909.
  • 2013. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clinical and Experimental Immunology. 263-272.
  • 2013. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. Journal of Clinical Immunology. 1341-1348.
  • 2013. A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds. Journal of Heredity. 807-820.
  • 2012. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 230-237.
  • 2012. Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. Journal of Clinical Endocrinology and Metabolism. 568-576.
  • 2012. Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. European Journal of Endocrinology. 507-516.
  • 2012. Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. Journal of Clinical Endocrinology and Metabolism. 1114-1124.
  • 2011. TSGA10 – A target for autoantibodies in autoimmune polyendocrine syndrome Type 1 and systemic lupus erythematosus. Scandinavian Journal of Immunology. 147-153.
  • 2011. Multiple loci in the HLA complex are associated with Addison's Disease. Journal of Clinical Endocrinology and Metabolism. E1703-E1708.
  • 2011. Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. Scandinavian Journal of Immunology. 327-333.
  • 2011. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. European Journal of Endocrinology. 345-352.
  • 2011. High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clinical Endocrinology. 753-759.
  • 2011. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. European Journal of Endocrinology. 761-769.
  • 2011. Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. BMC Medical Genetics. 6 pages.
  • 2011. Cellular immunity and immunopathology in autoimmune Addison’s disease. Molecular and Cellular Endocrinology. 180-190.
  • 2010. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. European Journal of Endocrinology. 453-459.
  • 2010. Sexuality and Fertility in Women with Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 4354-4360.
  • 2010. Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. Hypertension in Pregnancy. 399-405.
  • 2010. Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. Clinical Endocrinology. 641-647.
  • 2010. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scandinavian Journal of Immunology. 459-467.
  • 2010. Development of a Disease-Specific Quality of Life Questionnaire in Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 545-551.
  • 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. Journal of Experimental Medicine. 299-308.
  • 2010. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Annals of the Rheumatic Diseases. 1471-1474.
  • 2009. X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene. Journal of Clinical Endocrinology and Metabolism. 4086-4093.
  • 2009. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. Clinical Medicine : Case Reports. 4 pages.
  • 2009. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: The major autoantigen in autoimmune Addison's disease. Journal of Autoimmunity. 58-67.
  • 2009. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. Diabetes, obesity and metabolism. 304-314.
  • 2009. T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency. Journal of Clinical Endocrinology and Metabolism. 5117-5124.
  • 2009. Skin changes as diagnostic aid. Tidsskrift for Den norske legeforening. 752-752.
  • 2009. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proceedings of the National Academy of Sciences of the United States of America. 4396-4411.
  • 2009. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. Journal of Clinical Endocrinology and Metabolism. 5139-5145.
  • 2009. Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility. Journal of Clinical Endocrinology and Metabolism. 5139-5145.
  • 2009. Pathogenesis of primary adrenal insufficiency. Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism. 147-157.
  • 2009. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology. 233-237.
  • 2009. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. European Journal of Endocrinology. 993-1002.
  • 2009. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes, obesity and metabolism. 1034-1049.
  • 2009. Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. Journal of Clinical Endocrinology and Metabolism.
  • 2009. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. Journal of Clinical Endocrinology and Metabolism. 4882-4890.
  • 2009. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. Journal of Internal Medicine. 514-529.
  • 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity. 120-124.
  • 2009. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis. Annals of the Rheumatic Diseases.
  • 2008. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology. 163-169.
  • 2008. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism. 3310-3317.
  • 2008. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. European Journal of Human Genetics. 977-982.
  • 2008. Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. Journal of Neuro-Oncology. 251-259.
  • 2008. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 2657-2666.
  • 2008. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. European Journal of Endocrinology. 705-709.
  • 2008. Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen. New England Journal of Medicine. 1018-1028.
  • 2008. Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. Journal of Clinical Endocrinology and Metabolism. 4389-4397.
  • 2008. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes and Immunity. 130-136.
  • 2008. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity.
  • 2007. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proceedings of the National Academy of Sciences of the United States of America. 949-954.
  • 2007. Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scandinavian Journal of Immunology. 555-558.
  • 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Biochemical and Biophysical Research Communications - BBRC. 692-698.
  • 2007. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology. 109-112.
  • 2007. Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure. Acta Neurologica Scandinavica. 64-67.
  • 2007. Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. Journal of Clinical Endocrinology and Metabolism. 595-603.
  • 2006. The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. Endocrinology. 2411-2416.
  • 2006. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. Journal of Endocrinological Investigation. 727-731.
  • 2006. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. Scandinavian Journal of Immunology. 325-335.
  • 2006. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Medicine. 1152-1164.
  • 2005. Primær binyrebarksvikt - årsaker, diagnostikk og behandling (=Primary adrenal failure - Causes, diagnostics and therapy). Tidsskrift for Den norske legeforening. 155-158.
  • 2005. Primær binyrebarksvikt - årsaker, diagnostikk og behandling. Tidsskrift for Den norske legeforening. 155-158.
  • 2005. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Research.
  • 2005. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Research. 55-58.
  • 2005. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 210-213.
  • 2004. Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. British Journal of Cancer. 1508-1514.
  • 2004. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. Journal of Clinical Endocrinology and Metabolism. 544-547.
  • 2004. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. Journal of Clinical Endocrinology and Metabolism. 3474-3476.
  • 2004. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. Journal of Neurology. 197-203.
  • 2004. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. European Journal of Pediatrics. 604-611.
  • 2004. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. European Journal of Pediatrics. 604-611.
  • 2004. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. European Journal of Endocrinology. 49-56.
  • 2004. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. Journal of Clinical Endocrinology and Metabolism. 1636-1640.
  • 2003. Replacement therapy in Addison's disease. Expert Opinion on Pharmacotherapy. 2145-2149.
  • 2003. Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Healt Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial. Journal of Clinical Endocrinology and Metabolism. 1112-1118.
  • 2003. Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. Journal of Clinical Endocrinology and Metabolism. 1445-1452.
  • 2003. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scandinavian Journal of Gastroenterology. 511-515.
  • 2003. Døgnrytme til besvær. Tidsskrift for Den norske legeforening. 1858-1859.
  • 2002. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology. 581-588.
  • 2002. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. European Journal of Endocrinology. 583-589.
  • 2002. Mutational analysis of the autoimmune regulator gene in sporadic autoimmune Addison`s disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. European Journal of Endocrinology. 519-522.
  • 2002. High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology. 787-791.
  • 2002. Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scandinavian Journal of Gastroenterology. 732-737.
  • 2002. Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. Journal of Clinical Endocrinology and Metabolism. 618-623.
  • 2002. Autoimmune Regulator and Human Leucocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype. Journal of Clinical Endocrinology and Metabolism. 2568-2574.
  • 2001. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. Journal of Biological Chemistry. 35390-35395.
  • 2001. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics. 49-54.
  • 2001. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clinical Endocrinology. 211-217.
  • 2001. Acute adrenal insufficiency--symptoms and treatment. Tidsskrift for Den norske legeforening. 1260.
  • 2000. Pteridine-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 2944-2950.
  • 2000. Pteridin dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 2944-2950.
  • 2000. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology. 775-780.
  • 2000. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology. 775-780.
  • 2000. Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. Clinical and Experimental Immunology. 420-423.
  • 2000. Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. Clinical and Experimental Immunology. 420-423.
  • 2000. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochemical and Biophysical Research Communications - BBRC. 456-461.
  • 2000. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochemical and Biophysical Research Communications - BBRC. 456-461.
  • 2000. Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 460-463.
  • 2000. Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 460-463.
  • 1999. Antibodies Against Hair Follicles are Associated with Alopecia Totalis in Autoimmune Polyendocrine Syndrome Type I. Journal of Investigative Dermatology. 1054-1058.
  • 1998. Three sisters with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 4204-4206.
  • 1998. Primær binyrebarksvikt - en diagnostisk utfordring. Tidsskrift for Den norske legeforening. 542-544.
  • 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet. 279-283.
  • 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet. 279-283.
  • 1998. A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the Von Hippel Lindau disease or ret genes. Clinical Endocrinology. 11-16.
  • 1998. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clinical Endocrinology. 609-614.
  • 1997. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Letters. 439-445.
  • 1997. Chromogranin A and chromogranin B in phaeochromocytoma. European Journal of Endocrinology. 67-73.
  • 1997. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I correlate with the presence of autoimmune hepatitis and vitiligo. Journal of Clinical Endocrinology and Metabolism. 147-150.
Academic lecture
  • 2005. Variable expression of FKBP51 in Addison's Disease - a parameter of glucocorticoid sensitivity ?
  • 2005. Severe neurological impairment in patient with allgrove syndrome caused by frame shift mutation G363X (1066-1067delCT) and novel missense mutation W272S (TGG->TCG).
  • 2005. Ganglioneuroma in patient with adrenal insufficiency - rare coincidence of adrenal cortex and medulla disorders.
  • 2005. Cellular immunity to 21-hydroxylase in patients with autoimmune Addison's disease.
  • 2003. Meet the expert session on "Hypoadrenalism: substitution by corticoids and androgens".
  • 2003. Autoimmune polyendocrine syndromes.
  • 2003. Autoimmune Addisons disease and polyendocrine syndromes.
  • 2002. Prevalens og insidens av Addison's sykdom i Vest-Norge Livskvalitet hos pasienter med Addison's sykdom.
  • 2002. Pituitary tumours in multiple endocrine neoplasia type 1.
  • 2002. Høy forekomst av cøliaci hos pasienter med autoimmun binyrebarksvikt.
  • 2002. Dehydroepiandrosterone replacement in adrenal failure.
  • 2002. Autoimmune polyendocrine syndromes.
  • 2001. Klinisk handläggning av APS I patienter.
  • 2001. Autoimmun primær binyrebarksvikt i Norge. Autoantistoffer og HLA klasse II assosiasjoner relatert til kliniske manifestasjoner.
  • 1997. Ductal autoantigens in Sjøgren's syndrome.
Abstract
  • 2013. Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. Experimental and clinical endocrinology & diabetes. 2 pages.
  • 2013. Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. Scandinavian Journal of Immunology. 306-307.
  • 2013. Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 310-310.
  • 2012. Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease? Immunology. 300-301.
  • 2012. Mice deficient for the autoimmune regulator, Aire, display altered T cell responses against 21-hydroxylase, the major autoantigen in autoimmune Addison's disease. Immunology. 542-542.
  • 2012. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyedocrine sydnrome type I. Immunology. 673-674.
  • 2012. Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. Immunology. 211-212.
  • 2011. Oral manifestations of autoimmune polyendocrine syndrome type I. Caries Research. 186-187.
  • 2011. Endogenous Production of CXC Chemokine Ligand 10 (CXCL10) by Adrenocortical Cells and its Implications for Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 371-371.
  • 2011. Cytokine Antibodies in Autoimmune Polyendocrine Syndrome Type I Correlates to Chronic candidiasis. Scandinavian Journal of Immunology. 379-379.
  • 2010. The Possible Roles of Interferon-Gamma, CXC Chemokine Ligand 10 (CXCL10) and the CXCR3 Circuit in the Pathogenesis of Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 479-480.
  • 2010. Sexuality, Fertility and Androgens in Women with Addison's Disease. Endocrine reviews. 3.
  • 2010. Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). Scandinavian Journal of Immunology. 493-494.
  • 2010. Immunoreactivity against kidney collecting ducts in patients with autoimmune polyendocrine syndrome type 1 and systemic hypertension. Endocrine journal. S641-S641.
  • 2010. Grapefruit and Liquorice Increase Bioavailable Cortisol in Addison's Disease. Endocrine reviews. 1 pages.
  • 2009. Loss of AIRE Expression in Thymoma Tissue Associated with Multiple Endocrine Autoimmunity: A Novel Case of APS1. Clinical Immunology. S128-S128.
  • 2008. 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. Scandinavian Journal of Immunology. 191-191.
  • 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Scandinavian Journal of Immunology. 592-592.
Academic literature review
  • 2018. Autoimmune polyendocrine syndromes. 1132-1141.
  • 2016. Management of endocrine disease - Epidemiology, quality of life and complications of primary adrenal insufficiency: A review. R107-R116.
  • 2016. Autoimmune regulator and self-tolerance - molecular and clinical aspects. 127-140.
  • 2016. AIRE-mutations and autoimmune disease. 8-15.
  • 2010. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. 479-487.
  • 2009. Immunology of Addison's Disease and premature ovarian failure. 389-405.
  • 2009. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. 1-20.
  • 2008. Replacement therapy for Addison's disease: recent developments. 497-509.

More information in national current research information system (CRIStin)

Consultant in endocrinology and internal medicine

Co-ordinator of the EU FP7 project Euradrenal